Pulse Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Pulse Biosciences

10/08/2022 22:04

* Pulse Biosciences Inc  PLSE.OQ  reported a quarterly
adjusted
loss of 44 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 40 cents per share.
    * Revenue was $265.00 thousand​; analysts expected $439.67
thousand. 
    * Pulse Biosciences Inc's reported EPS for the quarter was a
loss
of 44 cents​.
    * The mean earnings estimate of analysts had risen by
about 15% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulse Biosciences Inc shares had risen by 4.6% this
quarter and
lost 89.2% so far this year.
    * The company reported a quarterly loss of $14 million.
    * Wall Street's median 12-month price target for Pulse
Biosciences
Inc is $5.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 09:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.40          -0.44          Missed
 Mar. 31 2022      -0.52          -0.58          Missed
 Dec. 31 2021      -0.51          -0.52          Missed
 Sep. 30 2021      -0.53          -0.48          Beat